Skip to main content
Premium Trial:

Request an Annual Quote

LifeLabs, Multiplex Genomics Partner on Coronavirus Testing in Canada

NEW YORK — Laboratory services firm LifeLabs said on Tuesday that it has partnered with Multiplex Genomics to perform SARS-CoV-2 testing and track virus variants in Canada.

Through the alliance, Toronto-based LifeLabs will provide SARS-CoV-2 test samples that Multiplex Genomics will analyze in order to confirm positive or negative results. Multiplex Genomics — a spinout of the University of Guelph's Centre for Biodiversity Genomics — will also sequence positive samples in order to assign them to SARS-CoV-2 variants.

The companies aim to analyze 20,000 COVID-19 samples a day, with the goal of increasing their capacity to 50,000 tests daily by the middle of the year, LifeLabs said.

"This made-in-Canada solution combines LifeLabs' deep operational and supply chain experience with Multiplex Genomics' innovative diagnostic processes, allowing Canada to rapidly scale its testing capacity to meet increased demand at a time when we need it most," LifeLabs President and CEO Charles Brown said in a statement.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.